LearnGlossaryMarketStocksSuperinvestorsSign in

IRWD

Ironwood Pharmaceuticals, Inc.

Healthcare · $680M market cap

Verdict

Share price

$3.64

close of Oct 3, 2026

Fair value

$3.64

Sticker Price

Payback Price

$1.45

buy price

Fairly Valued

IRWD is Fairly Valued: at $3.64 it's right at its fair value of $3.64. Its buy price (Payback Price) is $1.45, 60% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow. Sales grew -10% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth1.1% a year✗
Equity per share growth7.6% a year✗
Sales growth14.9% a year✓
Free cash flow growth-16.3% a year✗
Return on invested capital9.3%✗

Follow IRWD

Get notified when it reaches its buy price of $1.45. Free.

Create a free account

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic…

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works